Allen Mooney & Barnes Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.98M Sell
15,709
-825
-5% -$109K 0.3% 54
2026
Q1
$2.3M Buy
16,534
+3
+0% +$420 0.33% 52
2025
Q4
$2.03M Buy
16,531
+247
+2% +$30K 0.31% 53
2025
Q3
$1.81M Sell
16,284
-342
-2% -$38.9K 0.28% 53
2025
Q2
$1.84M Buy
16,626
+4
+0% +$426 0.3% 53
2025
Q1
$1.86M Sell
16,622
-106
-0.6% -$10.9K 0.3% 56
2024
Q4
$1.55M Sell
16,728
-2,205
-12% -$199K 0.26% 57
2024
Q3
$1.59M Sell
18,933
-1,393
-7% -$106K 0.27% 56
2024
Q2
$1.39M Sell
20,326
-326
-2% -$21.8K 0.25% 59
2024
Q1
$1.42M Sell
20,652
-386
-2% -$29.7K 0.27% 60
2023
Q4
$1.7M Buy
21,038
+212
+1% +$16.5K 0.32% 57
2023
Q3
$1.56M Sell
20,826
-71
-0.3% -$5.46K 0.33% 56
2023
Q2
$1.61M Buy
20,897
+275
+1% +$21.9K 0.36% 54
2023
Q1
$1.71M Sell
20,622
-981
-5% -$81.3K 0.41% 54
2022
Q4
$1.85M Sell
21,603
-29
-0.1% -$2.3K 0.45% 53
2022
Q3
$1.33M Sell
21,632
-629
-3% -$39.7K 0.36% 56
2022
Q2
$1.38M Sell
22,261
-845
-4% -$52.3K 0.35% 59
2022
Q1
$1.37M Buy
+23,106
New +$1.48M 0.3% 62

Other funds holding GILD

Allen Mooney & Barnes Investment Advisors's GILD Position: Q2 2026 in Review

Allen Mooney & Barnes Investment Advisors reduced its Gilead Sciences (GILD) stake by 5% in Q2 2026, selling an estimated $109K and leaving 15,709 shares worth $1.98M. The position accounts for 0.3% of the portfolio, ranked #54.

Allen Mooney & Barnes Investment Advisors first reported a position in GILD in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.3M in Q1 2026. 1,336 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Allen Mooney & Barnes Investment Advisors held 15,709 shares of Gilead Sciences worth $1.98M as of Q2 2026.
  • Allen Mooney & Barnes Investment Advisors sold 825 Gilead Sciences shares in Q2 2026, an estimated $109K.
  • Gilead Sciences made up 0.3% of Allen Mooney & Barnes Investment Advisors's portfolio in Q2 2026, its #54 holding.
  • Allen Mooney & Barnes Investment Advisors first reported a position in Gilead Sciences in Q1 2022 and has held it in 18 quarters since.
  • Allen Mooney & Barnes Investment Advisors's Gilead Sciences position peaked at $2.3M in Q1 2026.
  • 1,336 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Allen Mooney & Barnes Investment Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.